Showing results 1 to 20 of 71
next >
| Issue Date | Title | Author(s) |
| 2024-09 | Survivorship Care for People Affected by Advanced or Metastatic Cancer: MASCC-ASCO Standards and Practice Recommendations. | Hart, NH; Nekhlyudov, L; Smith, TJ; Yee, J; Fitch, MI; Crawford, GB; Koczwara, B; Ashbury, FD; Lustberg, MB; Mollica, M; Smith, AL; Jefford, M; Chino, F; Zon, R; Agar, MR; Chan, RJ |
| 2024-08-21 | Top Ten Tips Palliative Care Clinicians Should Know About Designing a Clinical Trial in Palliative Care. | Gurgenci, T; O'Leary, C; Philip, J; Bruera, E; Davis, M; Agar, MR; Hui, D; Zimmermann, C; Yennu, S; Hardy, J; Mercadante, S; Rosa, WE; Good, P |
| 2024-07-24 | Top Ten Tips Palliative Care Clinicians Should Know About Interpreting a Clinical Trial. | Gurgenci, T; O'Leary, C; Hui, D; Yennu, S; Bruera, E; Davis, M; Agar, MR; Zimmermann, C; Philip, J; Mercadante, S; Hardy, J; Rosa, WE; Good, P |
| 2024-07-01 | Unmet needs in people with high-grade glioma: defining criteria for stepped care intervention. | Faris, MM; Dhillon, HM; Campbell, R; Halkett, GKB; Miller, A; Chan, RJ; Haydon, HM; Sansom-Daly, UM; Koh, E-S; Ownsworth, T; Nowak, AK; Kelly, B; Leonard, R; Pike, KE; Legge, DM; Pinkham, MB; Agar, MR; BRAINS Program Group,; Shaw, J |
| 2024-07 | Community Preferences for the Care of Older People at the End of Life: How Important is the Disease Context? | Kenny, P; Street, DJ; Hall, J; Agar, MR; Phillips, J |
| 2024-06-03 | Patient-reported use of pancreatic enzyme replacement treatment (PERT) in pancreatic cancer in New Zealand and Australia: a cross-sectional survey study. | Landers, A; Brown, H; Al Ruheili, J; Russell, K; McKenzie, C; Agar, MR; Yenson, VM; Clarke, K; Windsor, J |
| 2024-04-29 | Survivorship care for people affected by advanced or metastatic cancer: MASCC-ASCO standards and practice recommendations. | Hart, NH; Nekhlyudov, L; Smith, TJ; Yee, J; Fitch, MI; Crawford, GB; Koczwara, B; Ashbury, FD; Lustberg, MB; Mollica, M; Smith, AL; Jefford, M; Chino, F; Zon, R; Agar, MR; Chan, RJ |
| 2024-04-08 | "You're the only thing he comes out [of his room] for": A qualitative study of engagement between Laughter Care Specialists and families of people with dementia in long-term care. | DiGiacomo, M; Roberts, S-J; Luckett, T; Symons, D; Ellis, G; Kochovska, S; Warner, T; Currow, DC; Parker, D; Payne, K; Agar, MR |
| 2023-10-12 | Participant Safety in Multisite, Randomized, Double-Blind, Placebo-Controlled Clinical Trials in Hospice/Palliative Care: Data from the Contracted Studies of the Australian National Palliative Care Clinical Studies Collaborative. | Currow, DC; Fazekas, B; Brown, L; Kochovska, S; Clark, K; Agar, MR |
| 2023-10 | Experience and acceptability of a carer-focussed intervention in acute oncology settings: A qualitative study of people with advanced cancer and their carers. | Marston, C; Morgan, DD; Philip, J; Agar, MR |
| 2023-10 | A Core Outcome Set for Interventions to Prevent and/or Treat Delirium in Palliative Care. | Bryans, A; Siddiqi, N; Burry, L; Clarke, M; Koffman, J; Agar, MR; Rose, L |
| 2023-10 | Exploring the clinical utility of a brief screening measure of unmet supportive care needs in people with high-grade glioma. | Campbell, R; Faris, M; Shaw, J; Halkett, GKB; Legge, D; Koh, E-S; Nowak, AK; Agar, MR; Ownsworth, T; Pike, KE; Chan, RJ; Dhillon, HM |
| 2023-09-22 | Exploring the practicality and acceptability a brief exercise communication and clinician referral pathway in cancer care: a feasibility study. | Caperchione, CM; English, M; Sharp, P; Agar, MR; Phillips, JL; Liauw, W; Harris, CA; McCullough, S; Lilian, R |
| 2023-09 | Acetazolamide versus placebo for cerebral oedema requiring dexamethasone in recurrent and/or progressive high-grade glioma: phase II randomised placebo-controlled double-blind study. | Agar, MR; Nowak, AK; Hovey, EJ; Barnes, EH; Simes, J; Vardy, JL; Wheeler, HR; Kong, BY; Leonard, R; Hall, M; Tim, E; Spyridopoulos, D; Sim, H-W; Lwin, Z; Dowling, A; Harrup, R; Jennens, R; Kichenadasse, G; Dunlop, T; Gzell, C; Koh, E-S |
| 2023-07-03 | Defining research priorities and needs in cancer symptoms for adults diagnosed with cancer: an Australian/New Zealand modified Delphi study. | Yenson, VM; Amgarth-Duff, I; Brown, L; Caperchione, CM; Clark, K; Cross, A; Good, P; Landers, A; Luckett, T; Philip, J; Steer, C; Vardy, JL; Wong, AK; Agar, MR |
| 2023-06-01 | Phase III, international, multicentre, double-blind, dose increment, parallel-arm, randomised controlled trial of duloxetine versus pregabalin for opioid-unresponsive neuropathic cancer pain. | Matsuoka, H; Clark, K; Fazekas, B; Oyamada, S; Brown, L; Ishiki, H; Matsuda, Y; Hasuo, H; Ariyoshi, K; Lee, J; Le, BH; Fujiwara, N; Miyaji, T; Agar, MR; Yamaguchi, T; Satomi, E; Iwase, S; Phillips, J; Koyama, A; Currow, DC |
| 2023-06-01 | Phase III, international, multicentre, double-blind, dose increment, parallel-arm, randomised controlled trial of duloxetine versus pregabalin for opioid-unresponsive neuropathic cancer pain | Matsuoka, H; Clark, K; Fazekas, B; Oyamada, S; Brown, L; Ishiki, H; Matsuda, Y; Hasuo, H; Ariyoshi, K; Lee, J; Le, BH; Fujiwara, N; Miyaji, T; Agar, MR; Yamaguchi, T; Satomi, E; Iwase, S; Phillips, J; Koyama, A; Currow, DC |
| 2023 | Subcutaneous ketamine infusion in palliative patients for major depressive disorder (SKIPMDD)-Phase II single-arm open-label feasibility study. | Lee, W; Sheehan, C; Chye, R; Chang, S; Bayes, A; Loo, C; Draper, B; Agar, MR; Currow, DC; Akena, D |
| 2023 | Mobile-Based Application Interventions to Enhance Cancer Control and Care in Low- and Middle-Income Countries: A Systematic Review. | Donkor, A; Ayitey, JA; Adotey, PN; Ofori, EO; Kitson-Mills, D; Vanderpuye, V; Opoku, SY; Luckett, T; Agar, MR; Engel-Hills, P |
| 2022-11-22 | Effect of Regular, Low-Dose, Extended-release Morphine on Chronic Breathlessness in Chronic Obstructive Pulmonary Disease: The BEAMS Randomized Clinical Trial. | Ekström, M; Ferreira, D; Chang, S; Louw, S; Johnson, MJ; Eckert, DJ; Fazekas, B; Clark, KJ; Agar, MR; Currow, DC; Australian National Palliative Care Clinical Studies Collaborative, |
